CN104606553A - Pharmaceutical composition for treating blood deficiency heat after delivery - Google Patents
Pharmaceutical composition for treating blood deficiency heat after delivery Download PDFInfo
- Publication number
- CN104606553A CN104606553A CN201510066306.1A CN201510066306A CN104606553A CN 104606553 A CN104606553 A CN 104606553A CN 201510066306 A CN201510066306 A CN 201510066306A CN 104606553 A CN104606553 A CN 104606553A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- pharmaceutical composition
- fever
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 20
- 239000008280 blood Substances 0.000 title abstract description 17
- 210000004369 blood Anatomy 0.000 title abstract description 17
- 230000007812 deficiency Effects 0.000 title abstract description 13
- 244000268590 Euryale ferox Species 0.000 claims abstract description 11
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 11
- 241000012101 Lindera megaphylla Species 0.000 claims abstract description 11
- 240000003433 Miscanthus floridulus Species 0.000 claims abstract description 11
- 241000243801 Tylorrhynchus Species 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 9
- 206010037660 Pyrexia Diseases 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 10
- 241000594394 Hedyotis Species 0.000 claims description 10
- 241000450714 Heterochaeta Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 241000125142 Seseli Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000007919 dispersible tablet Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241001102842 Cynanchum thesioides Species 0.000 abstract 1
- 241000445986 Embelia parviflora Species 0.000 abstract 1
- 241001336681 Hedyotis caudatifolia Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 abstract 1
- 241001213462 Holothuria leucospilota Species 0.000 abstract 1
- 244000182807 Mentha suaveolens Species 0.000 abstract 1
- 244000228295 Polygonum viviparum Species 0.000 abstract 1
- 235000012804 Polygonum viviparum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000128206 Pyracantha coccinea Species 0.000 abstract 1
- 235000003105 Pyracantha coccinea Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 235000016785 Rosa della China Nutrition 0.000 abstract 1
- 240000007620 Silaum silaus Species 0.000 abstract 1
- 235000002330 Silaum silaus Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000012174 chinese wax Substances 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 230000036760 body temperature Effects 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000013139 quantization Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010061245 Internal injury Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating blood deficiency heat after delivery. The pharmaceutical composition is prepared from the following materials in parts by weight: 10-20 parts of astragalus membranaceus, 5-15 parts of poria cocos, 10-20 parts of cynanchum thesioides, 1-10 parts of hairyvein agrimony herb, 10-20 parts of holothuria leucospilota, 5-15 parts of prepared fleece flower root, 1-10 parts of lindera megaphylla, 5-15 parts of bighead atractylodes rhizome, 10-20 parts of firethorn fruit, 10-20 parts of cortex lycii radicis, 1-10 parts of round-leaved mint leaf, 5-15 parts of China rose, 10-20 parts of polygonum viviparum, 10-20 parts of embelia parviflora, 5-15 parts of semen euryales leaves, 1-10 parts of Chinese wax, 10-20 parts of hedyotis caudatifolia, 1-10 parts of tylorrhynchus, 5-15 parts of limonitum, 5-15 parts of meadow saxifrage, 10-20 parts of miscanthus floridulus warb and 1-10 parts of liquorice root. The pharmaceutical composition disclosed by the invention can be used for nourishing blood and invigorating qi, harmonizing ying and reducing heat, warming and invigorating spleen and stomach; the pharmaceutical composition is significant in effect of treating blood deficiency heat after delivery, and is worthy of clinical popularization and application.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal.
Background technology
Heating is common disease clinically.Western medicine thinks that heating is that the body temperature caused by pyrogen raises, and treats based on ntipyretic analgesic medicine, optionally for pathogen administration of antibiotics class medicine.Heating is then divided into fever caused by exogenous pathogens and the large class of fever due to internal injury two by Chinese medicine.Different according to the cause of disease and the clinical symptoms of heating, it is dissimilar that fever due to internal injury comprises again the deficiency of vital energy, blood deficiency, the deficiency of YIN, yang deficiency, blood addiction, stagnate etc.Hemopenia fever is because of the heating caused by blood deficiency, tells that nosebleed is had blood in stool, metrorrhagia in puerperal or improper diet and overtiredness disorder of the spleen and stomach caused by internal damage all can cause hemopenia fever.The clinical manifestation of hemopenia fever has following several feature: (1) is common with low grade fever, and high heat also can appear in a few patients; (2) course of disease is longer, and often long-time low grade fever does not move back; (3) fever time is many in the afternoon to night; (4) patient's, menoxenia thin and delicate with shallow complexion or light Bai Buze, palpitation with irritability, insomnia and dreamful sleep, limb paralysis, lip pale tongue, pulse condition etc.
Puerpera is more owing to losing blood in production process, very easily causes hemopenia fever.Chinese medicine is thought, thin fluid injury, and cloudy blood is suddenly empty, and sun, without complied with, outside empty sun more floats on, is the Etiological of hemopenia fever in puerperal.Because puerpera's body constitution is comparatively special, therefore use the simple antipyretic-antalgic therapy for febrile conditions to be far from being enough, and Chinese medical discrimination therapy is by the merit of qi-supplementing, blood-engendering, stomach warming spleen invigorating, treatment hemopenia fever syndrome is comparatively effective, and safe and reliable, treating both the principal and secondary aspects of a disease.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal, it is made up of the material of following weight portion: Radix Astragali 10-20 part, Poria 5-15 part, Herba Cynanchi Thesioidis 10-20 part, Herba Agrimoniae 1-10 part, swing skin ginseng 10-20 part, Radix Polygoni Multiflori Preparata 5-15 part, Lindera megaphylla 1-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 10-20 part, Cortex Lycii 10-20 part, Radix Menthae Rotundifoliae 1-10 part, Flos Rosae Chinensis 5-15 part, Bulbilus dioscoreae 10-20 part, Radix seu Caulis Embeliae Parviflorae 10-20 part, Folium Euryales 5-15 part, Cera Chinensis 1-10 part, Herba Hedyotis Lanceae 10-20 part, Tylorrhynchus heterochaeta Quatrefages 1-10 part, Limonitum 5-15 part, Herba Seselis Seseloidis 5-15 part, Miscanthus floridulus (Labill.) Warb. 10-20 part, Radix Glycyrrhizae 1-10 part.
Preferably, of the present invention treatment puerperal hemopenia fever pharmaceutical composition be made up of the material of following weight portion: the Radix Astragali 15 parts, 10 parts, Poria, Herba Cynanchi Thesioidis 12 parts, Herba Agrimoniae 5 parts, swing skin join 15 parts, Radix Polygoni Multiflori Preparata 10 parts, Lindera megaphylla 8 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 15 parts, Cortex Lycii 12 parts, Radix Menthae Rotundifoliae 5 parts, Flos Rosae Chinensis 10 parts, Bulbilus dioscoreae 15 parts, Radix seu Caulis Embeliae Parviflorae 15 parts, Folium Euryales 12 parts, Cera Chinensis 5 parts, Herba Hedyotis Lanceae 15 parts, Tylorrhynchus heterochaeta Quatrefages 10 parts, Limonitum 12 parts, Herba Seselis Seseloidis 10 parts, Miscanthus floridulus (Labill.) Warb. 15 parts, 9 parts, Radix Glycyrrhizae.
More preferably, described pharmaceutical composition can be tablet, dispersible tablet, capsule, soft capsule or patch.
The present invention also provides the purposes of compositions in the medicine of preparation treatment hemopenia fever in puerperal, described compositions is made up of the material of following weight portion: Radix Astragali 10-20 part, Poria 5-15 part, Herba Cynanchi Thesioidis 10-20 part, Herba Agrimoniae 1-10 part, swing skin ginseng 10-20 part, Radix Polygoni Multiflori Preparata 5-15 part, Lindera megaphylla 1-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 10-20 part, Cortex Lycii 10-20 part, Radix Menthae Rotundifoliae 1-10 part, Flos Rosae Chinensis 5-15 part, Bulbilus dioscoreae 10-20 part, Radix seu Caulis Embeliae Parviflorae 10-20 part, Folium Euryales 5-15 part, Cera Chinensis 1-10 part, Herba Hedyotis Lanceae 10-20 part, Tylorrhynchus heterochaeta Quatrefages 1-10 part, Limonitum 5-15 part, Herba Seselis Seseloidis 5-15 part, Miscanthus floridulus (Labill.) Warb. 10-20 part, Radix Glycyrrhizae 1-10 part.
Preferably, described compositions is made up of the material of following weight portion: the Radix Astragali 15 parts, 10 parts, Poria, Herba Cynanchi Thesioidis 12 parts, Herba Agrimoniae 5 parts, swing skin join 15 parts, Radix Polygoni Multiflori Preparata 10 parts, Lindera megaphylla 8 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 15 parts, Cortex Lycii 12 parts, Radix Menthae Rotundifoliae 5 parts, Flos Rosae Chinensis 10 parts, Bulbilus dioscoreae 15 parts, Radix seu Caulis Embeliae Parviflorae 15 parts, Folium Euryales 12 parts, Cera Chinensis 5 parts, Herba Hedyotis Lanceae 15 parts, Tylorrhynchus heterochaeta Quatrefages 10 parts, Limonitum 12 parts, Herba Seselis Seseloidis 10 parts, Miscanthus floridulus (Labill.) Warb. 15 parts, 9 parts, Radix Glycyrrhizae.
More preferably, described medicine can be tablet, dispersible tablet, capsule, soft capsule or patch.
In the present compositions, Herba Hedyotis Lanceae, Tylorrhynchus heterochaeta Quatrefages, Miscanthus floridulus (Labill.) Warb. are monarch drug; The Radix Astragali, Poria, Herba Cynanchi Thesioidis, Herba Agrimoniae, swing skin ginseng, Radix Polygoni Multiflori Preparata is ministerial drug; Lindera megaphylla, the Rhizoma Atractylodis Macrocephalae, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae), Cortex Lycii, Radix Menthae Rotundifoliae, Flos Rosae Chinensis, Bulbilus dioscoreae, Radix seu Caulis Embeliae Parviflorae, Folium Euryales, Cera Chinensis, Limonitum, Herba Seselis Seseloidis are adjuvant drug; Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Pharmaceutical composition of the present invention, based on the relation of yang blood and qi, to be brought down a fever based on nourishing blood and invigorating qi, He Ying, warming and invigorating the spleen and stomach, is aided with clearing away heat to stop bleeding, menstruction regulating and pain relieving, treatment hemopenia fever Be very effective in puerperal, clinic application and promoting.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
The preparation of embodiment pharmaceutical composition of the present invention
For patch, the preparation technology of pharmaceutical composition of the present invention is as follows:
Take the Radix Astragali 150 grams, 100 grams, Poria, Herba Cynanchi Thesioidis 120 grams, Herba Agrimoniae 50 grams, swing skin and join 150 grams, Radix Polygoni Multiflori Preparata 100 grams, Lindera megaphylla 80 grams, the Rhizoma Atractylodis Macrocephalae 120 grams, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 150 grams, Cortex Lycii 120 grams, Radix Menthae Rotundifoliae 50 grams, Flos Rosae Chinensis 100 grams, Bulbilus dioscoreae 150 grams, Radix seu Caulis Embeliae Parviflorae 150 grams, Folium Euryales 120 grams, Cera Chinensis 50 grams, Herba Hedyotis Lanceae 150 grams, Tylorrhynchus heterochaeta Quatrefages 100 grams, Limonitum 120 grams, Herba Seselis Seseloidis 100 grams, Miscanthus floridulus (Labill.) Warb. 150 grams, 90 grams, Radix Glycyrrhizae, pulverize, cross 100 mesh sieves, add 3000 grams, vaseline, stir, spread upon on non-woven fabrics, evenly be cut into 100 pieces.
The curative effect of experimental example pharmaceutical composition of the present invention
1 data and method
1.1 physical data
This group hemopenia fever in puerperal patient 90 example, is divided into treatment group 50 example and matched group 40 example at random.The treatment group age between 21-37 year, 30.8 years old mean age; Wherein natural labor 19 example, Cesarean esction 31 example.The matched group mean age between 23-38,31.4 years old mean age; Wherein natural labor 14 example, Cesarean esction 26 example.The no significant difference (p > 0.05) of two groups of patient ages and childbirth options, has comparability.
1.2 diagnostic criteria
1.2.1 disease diagnostic criteria
All patients all meet the diagnostic criteria in " new Chinese medicine guideline of clinical investigations ": 1. generate heat.Body temperature >=37.5 DEG C (auxillary temperature), measure every day 4 times (when 2,8 time, 14 time, 20 time); 2. syndrome of deficiency of blood.Primary symptom: pale white complexion or sallow, dizziness and blurred vision, cardiopalmus; Secondary disease: insomnia, numb hand and foot, thready pulse, light red tongue.Possess above-mentioned primary symptom 2 and can specify syndrome of deficiency of blood diagnosis with time disease more than 2 persons.
1.2.2 disease scalar quantization is marked
According to " new Chinese medicine guideline of clinical investigations ", carry out the scoring of disease scalar quantization with the method for patient's readme according to table 1 below:
Table 1 hemopenia fever disease scalar quantization grade form
1.3 Therapeutic Method
Treatment group uses the patch prepared in embodiment to treat, every day 2 times, each forehead using one piece of patch to be attached to patient.The oral Renshen Guipi Wan of matched group (strong spring board, Tianjin Darentang Pharmaceutical Factory is produced), 1 ball/time, 2 times/day.Two groups was all a course for the treatment of with 7 days, treated a course for the treatment of.
1.4 criterion of therapeutical effect
After treatment, the body temperature numerical value of the 1st, 3,5,7 day record two groups of patients, calculates therapeutic index (N) and effective percentage according to the Quantitative marking score value before and after treatment.
Criterion of therapeutical effect is formulated as follows according to " new Chinese medicine guideline of clinical investigations ".Recovery from illness: temperature recovery is normal, and blood deficiency symptom, sign disappear substantially, N >=95%; Effective: temperature recovery is normal, and blood deficiency symptom, sign are obviously improved, N >=75%; Take a turn for the better: temperature decline but still higher than normally, blood deficiency symptom, sign all take a favorable turn, N >=30%; Invalid: body temperature does not decline, higher than normally, blood deficiency symptom, sign are not improved, N < 30%.Wherein:
Score value × 100% before N=(before treatment the rear score value of score value-treatment)/treatment
Effective percentage=(cure+effective+take a turn for the better) number of cases/total number of cases × 100%
1.5 statistical analysis
Adopt the capable statistical analysis of SPSS18.0 software.Measurement data with
represent, adopt t inspection; Enumeration data adopts x
2inspection.With p < 0.05 for difference has statistical significance.
2 results
2.1 Temperature changing
Two groups of patients body temperature no significant difference before the treatment (p > 0.05), and the body temperature of the 3rd, 5,7 day all had decline compared with the 1st day after treatment, difference all has statistical significance (p<0.05), and compared with matched group, treatment group declines more obvious the 5th day and the 7th day, group difference has statistical significance (p<0.05).Specifically in table 2.
The comparison of table 2 liang group patient temperature change
Note: compare with before treatment, * p<0.05; Compare with matched group, * * p<0.05
2.2 scoring score value changes
Two groups of patients scoring score value not statistically significant (p > 0.05) before the treatment, and after treating 7 days, the scoring score value of two groups declines all to some extent, difference has statistical significance (p<0.05), and treatment group comparatively matched group decline more obvious, group difference has statistical significance (p<0.05).Specifically in table 3.
Table 3 liang group patient marks the comparison of score value change
Note: compare with before treatment, * p<0.05; Compare with matched group, * * p<0.05
2.3 effective percentage
Table 4 is below shown in two groups of efficient interpretations of result.Through x
2inspection, the effective percentage of two groups of patients after treatment has significant difference (p<0.05).
A table 4 liang group effective percentage compares
Note: compare with matched group, * p<0.05
Above result shows, the improvement for the treatment of group symptom is all better than matched group, and pharmaceutical composition of the present invention has significant advantage in hemopenia fever in treatment puerperal.
Claims (6)
1. treat the pharmaceutical composition of hemopenia fever in puerperal for one kind, it is characterized in that, it is made up of the material of following weight portion: Radix Astragali 10-20 part, Poria 5-15 part, Herba Cynanchi Thesioidis 10-20 part, Herba Agrimoniae 1-10 part, swing skin ginseng 10-20 part, Radix Polygoni Multiflori Preparata 5-15 part, Lindera megaphylla 1-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 10-20 part, Cortex Lycii 10-20 part, Radix Menthae Rotundifoliae 1-10 part, Flos Rosae Chinensis 5-15 part, Bulbilus dioscoreae 10-20 part, Radix seu Caulis Embeliae Parviflorae 10-20 part, Folium Euryales 5-15 part, Cera Chinensis 1-10 part, Herba Hedyotis Lanceae 10-20 part, Tylorrhynchus heterochaeta Quatrefages 1-10 part, Limonitum 5-15 part, Herba Seselis Seseloidis 5-15 part, Miscanthus floridulus (Labill.) Warb. 10-20 part, Radix Glycyrrhizae 1-10 part.
2. according to claim 1 treatment puerperal hemopenia fever pharmaceutical composition, it is made up of the material of following weight portion: the Radix Astragali 15 parts, 10 parts, Poria, Herba Cynanchi Thesioidis 12 parts, Herba Agrimoniae 5 parts, swing skin join 15 parts, Radix Polygoni Multiflori Preparata 10 parts, Lindera megaphylla 8 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 15 parts, Cortex Lycii 12 parts, Radix Menthae Rotundifoliae 5 parts, Flos Rosae Chinensis 10 parts, Bulbilus dioscoreae 15 parts, Radix seu Caulis Embeliae Parviflorae 15 parts, Folium Euryales 12 parts, Cera Chinensis 5 parts, Herba Hedyotis Lanceae 15 parts, Tylorrhynchus heterochaeta Quatrefages 10 parts, Limonitum 12 parts, Herba Seselis Seseloidis 10 parts, Miscanthus floridulus (Labill.) Warb. 15 parts, 9 parts, Radix Glycyrrhizae.
3. the pharmaceutical composition for the treatment of hemopenia fever in puerperal according to claim 1 and 2, it is characterized in that, described pharmaceutical composition can be tablet, dispersible tablet, capsule, soft capsule or patch.
4. the purposes of compositions in the medicine of preparation treatment hemopenia fever in puerperal, it is characterized in that, described compositions is made up of the material of following weight portion: Radix Astragali 10-20 part, Poria 5-15 part, Herba Cynanchi Thesioidis 10-20 part, Herba Agrimoniae 1-10 part, swing skin ginseng 10-20 part, Radix Polygoni Multiflori Preparata 5-15 part, Lindera megaphylla 1-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 10-20 part, Cortex Lycii 10-20 part, Radix Menthae Rotundifoliae 1-10 part, Flos Rosae Chinensis 5-15 part, Bulbilus dioscoreae 10-20 part, Radix seu Caulis Embeliae Parviflorae 10-20 part, Folium Euryales 5-15 part, Cera Chinensis 1-10 part, Herba Hedyotis Lanceae 10-20 part, Tylorrhynchus heterochaeta Quatrefages 1-10 part, Limonitum 5-15 part, Herba Seselis Seseloidis 5-15 part, Miscanthus floridulus (Labill.) Warb. 10-20 part, Radix Glycyrrhizae 1-10 part.
5. purposes according to claim 4, wherein said compositions is made up of the material of following weight portion: the Radix Astragali 15 parts, 10 parts, Poria, Herba Cynanchi Thesioidis 12 parts, Herba Agrimoniae 5 parts, swing skin join 15 parts, Radix Polygoni Multiflori Preparata 10 parts, Lindera megaphylla 8 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Fructus Pyracanthae (Fructus Pyracanthae Fortuneanae) 15 parts, Cortex Lycii 12 parts, Radix Menthae Rotundifoliae 5 parts, Flos Rosae Chinensis 10 parts, Bulbilus dioscoreae 15 parts, Radix seu Caulis Embeliae Parviflorae 15 parts, Folium Euryales 12 parts, Cera Chinensis 5 parts, Herba Hedyotis Lanceae 15 parts, Tylorrhynchus heterochaeta Quatrefages 10 parts, Limonitum 12 parts, Herba Seselis Seseloidis 10 parts, Miscanthus floridulus (Labill.) Warb. 15 parts, 9 parts, Radix Glycyrrhizae.
6. the purposes according to claim 4 or 5, wherein said medicine can be tablet, dispersible tablet, capsule, soft capsule or patch.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510066306.1A CN104606553B (en) | 2015-02-10 | 2015-02-10 | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal |
| CN201510425324.4A CN104971252A (en) | 2015-02-10 | 2015-02-10 | Pharmaceutical composition for treating postnatal blood deficiency-heat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510066306.1A CN104606553B (en) | 2015-02-10 | 2015-02-10 | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510425324.4A Division CN104971252A (en) | 2015-02-10 | 2015-02-10 | Pharmaceutical composition for treating postnatal blood deficiency-heat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104606553A true CN104606553A (en) | 2015-05-13 |
| CN104606553B CN104606553B (en) | 2015-09-23 |
Family
ID=53141374
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510425324.4A Pending CN104971252A (en) | 2015-02-10 | 2015-02-10 | Pharmaceutical composition for treating postnatal blood deficiency-heat |
| CN201510066306.1A Expired - Fee Related CN104606553B (en) | 2015-02-10 | 2015-02-10 | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510425324.4A Pending CN104971252A (en) | 2015-02-10 | 2015-02-10 | Pharmaceutical composition for treating postnatal blood deficiency-heat |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN104971252A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020008725A (en) * | 2000-07-25 | 2002-01-31 | 유종근 | Health Drink of JEBICHA Using the Pumpkin and Medicinal Herbs and Manufacturi ng Method Thereof |
| CN101513519A (en) * | 2008-02-22 | 2009-08-26 | 北京亚东生物制药有限公司 | Chinese medicinal composition for invigorating Qi and nourishing blood, preparation method and quality control method thereof |
| CN103230548A (en) * | 2013-05-06 | 2013-08-07 | 孙永权 | Traditional Chinese medicine composition for treating pulmonary heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101112518A (en) * | 2007-08-29 | 2008-01-30 | 北京艺信堂医药研究所 | Chinese traditional medicine preparations for treating postpartum blood deficiency and fever |
| CN102579799B (en) * | 2012-03-06 | 2013-09-25 | 孙雪晶 | Traditional Chinese medicine composition for treating postpartum fever with blood deficiency |
-
2015
- 2015-02-10 CN CN201510425324.4A patent/CN104971252A/en active Pending
- 2015-02-10 CN CN201510066306.1A patent/CN104606553B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020008725A (en) * | 2000-07-25 | 2002-01-31 | 유종근 | Health Drink of JEBICHA Using the Pumpkin and Medicinal Herbs and Manufacturi ng Method Thereof |
| CN101513519A (en) * | 2008-02-22 | 2009-08-26 | 北京亚东生物制药有限公司 | Chinese medicinal composition for invigorating Qi and nourishing blood, preparation method and quality control method thereof |
| CN103230548A (en) * | 2013-05-06 | 2013-08-07 | 孙永权 | Traditional Chinese medicine composition for treating pulmonary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 吴志香: "发热的中医论治", 《中国实用乡村医生杂志》, vol. 15, no. 10, 31 October 2008 (2008-10-31) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104606553B (en) | 2015-09-23 |
| CN104971252A (en) | 2015-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432545A (en) | Medicament for allaying fever of child and preparation method thereof | |
| CN101670011A (en) | Medicament for treating rheumatism and rheumatoid and preparation method thereof | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN102366517A (en) | Chinese herbal medicine preparation for preventing and treating qi-blood weakness | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN105031454A (en) | Medicine for treating pulmonary tuberculosis | |
| CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN104306662A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method thereof | |
| CN104606553B (en) | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN104606484A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency and preparation method thereof | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN104398958A (en) | Tablet for treating leukemia | |
| CN103393954A (en) | Preparation method of ointment for helping rehabilitation of peroneal nerve injury | |
| CN103110743B (en) | Traditional Chinese medicine composition for treating or preventing neurasthenia and preparation method thereof | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN103432321A (en) | Chinese patent medicine and traditional Chinese medicine decoction both capable of effectively treating abdominal pain due to collapse from qi deficiency | |
| CN102552570B (en) | Medicine for treating acra necrosis after bone trauma | |
| CN107595998B (en) | Traditional Chinese medicine composition for stroke convalescence and preparation method thereof | |
| CN105770815A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof | |
| CN105535817A (en) | A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof | |
| CN105688068A (en) | Chinese herbal preparation for treating arrhythmia and preparing method of Chinese herbal preparation | |
| CN102895322B (en) | Medicament composition for treating pulmonary interstitial fibrosis as well as preparation method and applications thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY Free format text: FORMER OWNER: REN HONGXIA Effective date: 20150819 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhou Jun Inventor after: Li Jing Inventor after: Zhang Ning Inventor after: Tan Ping Inventor before: Ren Hongxia |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: REN HONGXIA TO: ZHOU JUN LI JING ZHANG NING TAN PING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150819 Address after: 266000 Shandong city of Qingdao province Jiangsu City Road No. 16 Applicant after: Affiliated Hospital of University Of Qingdao Address before: 050035 No. 18 Changjiang Road, Shijiazhuang hi tech Development Zone, Hebei, China Applicant before: Ren Hongxia |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150923 Termination date: 20160210 |